Showing results (51-60 of 124) with videos related to

Sort By:
Pageof 13
International Journal of Cancer|September 30, 2004
Lower levels of nuclear beta-catenin predict for a poorer prognosis in localized prostate cancerLisa G Horvath, Susan M Henshall, C-Soon Lee, et al.
British Journal of Cancer|August 15, 2019
p53 nuclear accumulation as an early indicator of lethal prostate cancerDavid I Quinn, Phillip D Stricker, James G Kench, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 15, 2023
Patient-Reported Outcome Measures in Chemotherapy-Induced Peripheral Neurotoxicity: Defining Minimal and Clinically Important ChangesTiffany Li, Hannah C Timmins, Terry Trinh, et al.
The Journal of Pathology|March 26, 2021
Inhibition of guanosine monophosphate synthetase (GMPS) blocks glutamine metabolism and prostate cancer growthQian Wang, Yi Fang Guan, Sarah E Hancock, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 3, 2024
Evaluating a shared care pathway intervention for people receiving chemotherapy to reduce post-treatment unplanned hospital presentations: a randomised controlled trialJudith Fethney, Bora Kim, Chantale Boustany, et al.
JCO Precision Oncology|July 29, 2024
Circulating Lipid Profiles Associated With Resistance to Androgen Deprivation Therapy in Localized Prostate CancerHui-Ming Lin, Xiaoyu Yang, Margaret M Centenera, et al.
JCO Oncology Practice|September 24, 2020
Evaluation of a Mainstream Model of Genetic Testing for Men With Prostate CancerTahlia Scheinberg, Annabel Goodwin, Emilia Ip, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
Membranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitroLisa G Horvath, Susan M Henshall, James G Kench, et al.
Pageof 13